Charter Hall Group (ASX:CHC)
Australia · Delayed Price · Currency is AUD 19.92
-0.28 (-1.39%)
Aug 1, 2025, 4:10 PM AEST
CTI BioPharma Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2020 |
Net Income | -152.9 | -222.1 | 196.1 | 911.1 | 476.8 | 348.1 | Upgrade |
Depreciation & Amortization | -35.3 | 13.1 | 9.9 | 9.9 | 9.3 | 18.8 | Upgrade |
Loss (Gain) From Sale of Assets | 8.8 | 8.8 | 0.9 | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | -9.7 | -9.7 | -2.3 | 1 | -30.9 | 8.5 | Upgrade |
Loss (Gain) From Sale of Investments | 64.6 | 64.6 | 8.6 | 18.2 | 6.5 | -1.9 | Upgrade |
Stock-Based Compensation | 17.1 | 17.1 | 12.6 | 12.4 | 7 | 9.9 | Upgrade |
Other Operating Activities | -99.3 | 18.6 | 3.3 | -8.3 | 20.8 | 3.1 | Upgrade |
Change in Accounts Receivable | 47.5 | 47.5 | -44.4 | 1.6 | -16.6 | 48.4 | Upgrade |
Change in Accounts Payable | -9.9 | -9.9 | -35.4 | 63.2 | 26.2 | 13.9 | Upgrade |
Change in Income Taxes | -28.3 | -28.3 | -36.1 | 51.1 | - | - | Upgrade |
Change in Other Net Operating Assets | 539.2 | 539.2 | 230.2 | -466.3 | -254 | -63.2 | Upgrade |
Operating Cash Flow | 330.9 | 428 | 338.9 | 603.8 | 225.6 | 402.6 | Upgrade |
Operating Cash Flow Growth | -29.94% | 26.29% | -43.87% | 167.64% | -43.96% | 115.99% | Upgrade |
Capital Expenditures | -2.2 | -2.5 | -2.3 | -11.1 | -5.6 | -6.9 | Upgrade |
Divestitures | - | - | - | 49.3 | - | - | Upgrade |
Sale (Purchase) of Real Estate | -78.8 | -78.8 | - | -133 | -22.7 | -55.9 | Upgrade |
Investment in Securities | -144 | -174.7 | -318.8 | -263.7 | -156.2 | -128.9 | Upgrade |
Other Investing Activities | - | - | - | - | 4.2 | 47.1 | Upgrade |
Investing Cash Flow | -225 | -256 | -321.1 | -358.5 | -180.3 | -144.6 | Upgrade |
Long-Term Debt Issued | - | 37.5 | - | 126.2 | 269 | 331.1 | Upgrade |
Long-Term Debt Repaid | - | -9.2 | -6.8 | -86.4 | -48.8 | -292.2 | Upgrade |
Net Debt Issued (Repaid) | 28.1 | 28.3 | -6.8 | 39.8 | 220.2 | 38.9 | Upgrade |
Repurchase of Common Stock | -24.2 | -11.2 | -8.9 | - | -20.5 | -20.1 | Upgrade |
Common Dividends Paid | -213.2 | -207.1 | -195.4 | -181.5 | -171.3 | -161.6 | Upgrade |
Other Financing Activities | -8.3 | -0.7 | - | 139.2 | 39.3 | 9.8 | Upgrade |
Financing Cash Flow | -217.6 | -190.7 | -211.1 | -2.5 | 67.7 | -133 | Upgrade |
Net Cash Flow | -111.7 | -18.7 | -193.3 | 242.8 | 113 | 125 | Upgrade |
Free Cash Flow | 328.7 | 425.5 | 336.6 | 592.7 | 220 | 395.7 | Upgrade |
Free Cash Flow Growth | -30.03% | 26.41% | -43.21% | 169.41% | -44.40% | 119.22% | Upgrade |
Free Cash Flow Margin | 57.34% | 71.18% | 38.65% | 35.56% | 21.75% | 54.09% | Upgrade |
Free Cash Flow Per Share | 0.69 | 0.90 | 0.70 | 1.24 | 0.47 | 0.84 | Upgrade |
Cash Interest Paid | 33.3 | 32 | 25.2 | 13.5 | 9.5 | 13.5 | Upgrade |
Cash Income Tax Paid | 108 | 133.4 | 165.5 | 112.7 | 75.1 | 57.7 | Upgrade |
Levered Free Cash Flow | 111.44 | 192.57 | 239.41 | 763.3 | 296.03 | 444.31 | Upgrade |
Unlevered Free Cash Flow | 131.25 | 213.32 | 256.23 | 772.68 | 302.22 | 453.37 | Upgrade |
Change in Net Working Capital | 51.1 | -9 | 35.2 | -60 | 65.4 | -148.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.